NCT05424276 - A Randomized, Double-Blind, Placebo-Controlled Trial of IkT-148009 in Untreated Parkinson's Disease | Biotech Hunter

Enrollment

120

Participants

Timeline

Start Date

May 15, 2023

Primary Completion Date

October 25, 2024

Study Completion Date

June 30, 2025

Conditions

Parkinson Disease

Interventions

DRUG

IkT-148009

Oral administration gelatin capsule

DRUG

Placebo

Oral administration gelatin capsule

Trial Locations (28)

27607

Neurology, Raleigh

27705

Neurology, Durham

29935

Neurology, Port Royal

33136

Neurology, Miami

33486

Neurologist, Boca Raton

33609

Neurology, Tampa

33613

Neurology, Tampa

34105

Neurology, Naples

37232

Neurology, Nashville

38137

Neurology, Memphis

43221

Neurology, Columbus

48334

Neurology, Farmington Hills

53226

Neurology, Milwaukee

53705

Neurology, Madison

55427

Neurology, Golden Valley

72205

Neurology, Little Rock

74136

Neurology, Tulsa

75035

Neurology, Frisco

77030

Neurology, Houston

78681

Neurology, Round Rock

85258

Neurology, Scottsdale

91335

Neurology, Reseda

97239

Neurology, Portland

98034

Neurology, Kirkland

06905

Neurology, Stamford

02035

Neurology, Foxborough

02747

Neurology, South Dartmouth

07764

Neurology, West Long Branch